Latest Brain tumor Stories
Industry and Academic Leader Co-Founded Several Successful Biotechnology Companies, Including Alnylam, Cubist and Alkermes SAN DIEGO, Feb.
- Updated Phase I/II clinical trial data on the maximum tolerated dose for VAL-083 in the treatment of glioblastoma multiforme (GBM) to be presented - VANCOUVER, British Columbia
RnRMarketResearch.com adds “Oligodendroglioma – Pipeline Review, H2 2014” report to its store.
NEW YORK, Feb. 19, 2015 /PRNewswire/ -- Novogen presented yesterday (Wednesday February 18) to an audience of stockholders, analysts, investors and investment bankers.
University Of Miami Brain Tumor Initiative, The Miami Children's Hospital Brain Cancer Initiative and Local Heroes to be Honored for their Tireless Support and Ongoing Hope for a Cure MIAMI,
BETHESDA, Md., Feb. 19, 2015 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
RnRMarketResearch.com adds “Malignant Glioma – Pipeline Review, H1 2015” report to its store.
- Management to host live investor conference call and webcast on February 17, 2015 at 1:30 PM PST - VANCOUVER, British Columbia and MENLO PARK, Calif., Feb.
CALGARY, Feb. 9, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.